Coya Therapeutics (COYA) Competitors

Canopy Growth (NASDAQ:CGC) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, community ranking, analyst recommendations, media sentiment, dividends and institutional ownership.

Which has higher earnings and valuation, CGC or COYA?

Coya Therapeutics has lower revenue, but higher earnings than Canopy Growth. Coya Therapeutics is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$220.27M	1.80	-$487.23M	-$4.93	-0.76
Coya Therapeutics	$9.55M	10.54	-$7.99M	-$0.65	-9.28

Do analysts rate CGC or COYA?

Canopy Growth presently has a consensus price target of $3.50, suggesting a potential downside of 6.91%. Coya Therapeutics has a consensus price target of $16.67, suggesting a potential upside of 176.40%. Given Coya Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Coya Therapeutics is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Coya Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media refer more to CGC or COYA?

In the previous week, Coya Therapeutics had 2 more articles in the media than Canopy Growth. MarketBeat recorded 8 mentions for Coya Therapeutics and 6 mentions for Canopy Growth. Coya Therapeutics' average media sentiment score of 0.81 beat Canopy Growth's score of 0.38 indicating that Coya Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Coya Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, CGC or COYA?

Canopy Growth has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.46, meaning that its stock price is 54% less volatile than the S&P 500.

Do institutionals & insiders have more ownership in CGC or COYA?

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 39.8% of Coya Therapeutics shares are held by institutional investors. 1.3% of Canopy Growth shares are held by company insiders. Comparatively, 12.0% of Coya Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Does the MarketBeat Community prefer CGC or COYA?

Canopy Growth received 6 more outperform votes than Coya Therapeutics when rated by MarketBeat users. However, 93.33% of users gave Coya Therapeutics an outperform vote while only 19.42% of users gave Canopy Growth an outperform vote.

Company	Underperform	Outperform
Canopy Growth	Outperform Votes 20 19.42%	Underperform Votes 83 80.58%
Coya Therapeutics	Outperform Votes 14 93.33%	Underperform Votes 1 6.67%

Is CGC or COYA more profitable?

Coya Therapeutics has a net margin of 0.00% compared to Canopy Growth's net margin of -186.17%. Coya Therapeutics' return on equity of -31.63% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-186.17%	-74.29%	-29.94%
Coya Therapeutics	N/A	-31.63%	-27.76%

Summary

Coya Therapeutics beats Canopy Growth on 14 of the 18 factors compared between the two stocks.